General Information of the Protein
Protein ID
PT01588
Protein Name
Corticotropin-releasing factor receptor 1
Secondarily
Protein Name
Corticotropin-releasing hormone receptor 1
Gene Name
CRHR1
Secondarily
Gene Name
CRFR
CRFR1
CRHR
Sequence
MGGHPQLRLVKALLLLGLNPVSASLQDQHCESLSLASNISGLQCNASVDLIGTCWPRSPAGQLVVRPCPAFFYGVRYNTTNNGYRECLANGSWAARVNYSECQEILNEEKKSKVHYHVAVIINYLGHCISLVALLVAFVLFLRLRPGCTHWGDQADGALEVGAPWSGAPFQVRRSIRCLRNIIHWNLISAFILRNATWFVVQLTMSPEVHQSNVGWCRLVTAAYNYFHVTNFFWMFGEGCYLHTAIVLTYSTDRLRKWMFICIGWGVPFPIIVAWAIGKLYYDNEKCWFGKRPGVYTDYIYQGPMILVLLINFIFLFNIVRILMTKLRASTTSETIQYRKAVKATLVLLPLLGITYMLFFVNPGEDEVSRVVFIYFNSFLESFQGFFVSVFYCFLNSEVRSAIRKRWHRWQDKHSIRARVARAMSIPTSPTRVSFHSIKQSTAV
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Membrane receptor
>
Family B G protein-coupled receptor
>
Peptide receptor (family B GPCR)
>
Corticotropin releasing factor receptor
>
Corticotropin releasing factor receptor
Function
G-protein coupled receptor for CRH (corticotropin-releasing factor) and UCN (urocortin). Has high affinity for CRH and UCN. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and down-stream effectors, such as adenylate cyclase. Promotes the activation of adenylate cyclase, leading to increased intracellular cAMP levels. Inhibits the activity of the calcium channel CACNA1H. Required for normal embryonic development of the adrenal gland and for normal hormonal responses to stress. Plays a role in the response to anxiogenic stimuli.
    Show/Hide
Uniprot ID
Primary ID:
P34998

Secondarily ID:
B4DIE9
Q13008
Q4QRJ1
Q9UK64
    Show/Hide
Ensembl ID
ENSG00000120088
HGNC ID
HGNC:2357
Subcellular Location
Cell membrane
Endosome
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000367 , AtT-20
Compound ID Compound Name Compound Formula
CP0478377
2-(4-chloro-2,6-dimethoxyphenyl)-4-methoxy-6-methyl-N,N-dipropylpyrimidin-5-amine
   Show/Hide
C20H28ClN3O3
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0486463
2-(4-chloro-2,6-dimethoxyphenyl)-4-methoxy-6-methyl-5-(pentan-3-yloxy)pyrimidine
   Show/Hide
C19H25ClN2O4
 1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CP0453236
1-(2-methoxy-4,6-dimethylphenyl)-3-methyl-N,N-dipropylisoquinolin-4-amine
   Show/Hide
C25H32N2O
 2
1
IC50 = 12 nM
   TI
   LI
   LO
   TS
2
Ki = 12 nM
   TI
   LI
   LO
   TS
CP0486464
4-methoxy-2-(2-methoxy-4,6-dimethylphenyl)-6-methyl-5-(pentan-3-yloxy)pyrimidine
   Show/Hide
C20H28N2O3
 1
1
IC50 = 19 nM
   TI
   LI
   LO
   TS
CP0471135
1-(2,4-bis(2,2-difluoroethyl)-6-methoxyphenyl)-3-methyl-N,N-dipropylisoquinolin-4-amine
   Show/Hide
C27H32F4N2O
 1
1
Ki = 22 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0035677
Pyrazolo[1,5-a]-1,3,5-triazine, 13-15
   Show/Hide
C18H24N6O
 1
1 IC50 = 6.1 nM
CP0311099
3,6-dimethyl-4-(pentan-3-yloxy)-2-(2,4,6-trimethylphenoxy)pyridine
   Show/Hide
C21H29NO2
 1
1 IC50 = 6.8 nM
CP0324234
N-(cyclopropylmethyl)-3-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-6-methyl-N-(oxan-4-ylmethyl)pyrazolo[5,1-b][1,3]thiazol-7-amine
   Show/Hide
C26H35N3O4S
 1
1 IC50 = 46 nM
CP0227068
N-(cyclopropylmethyl)-3-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-6-methoxy-N-(2-methoxyethyl)pyrazolo[5,1-b][1,3]thiazol-7-amine
   Show/Hide
C23H31N3O5S
 1
1 IC50 = 48 nM
CP0328875
US850504, 91
   Show/Hide
C26H34FN3O5S
 1
1 IC50 = 61 nM
CP0218317
N-(cyclopropylmethyl)-3-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-2,6-dimethyl-N-(oxan-4-ylmethyl)pyrazolo[5,1-b][1,3]thiazol-7-amine
   Show/Hide
C27H37N3O4S
 1
1 IC50 = 76 nM
CP0113466
8-(2,4-dichlorophenyl)-N-(1,3-dimethoxypropan-2-yl)-2,7-dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine
   Show/Hide
C18H21Cl2N5O2
 2
1 IC50 = 82 nM
2 Ki = 1.7 nM
CP0504853
8-(dipropylamino)-3-(2,4,6-trimethylanilino)-1H-quinoxalin-2-one
   Show/Hide
C23H30N4O
 2
1 IC50 = 100 nM
2 IC50 = 469 nM
CP0523128
3-methyl-5-N,5-N-dipropyl-2-N-(2,4,6-trimethylphenyl)quinoxaline-2,5-diamine
   Show/Hide
C24H32N4
 2
1 IC50 = 155 nM
2 IC50 = 563 nM
CP0039659
1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione
   Show/Hide
C30H16O8
 1
1 IC50 = 300 nM
CP0051881
(2S,3S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-5-carbamimidamido-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-carboxy-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-3-carboxy-2-[[(2S,3S)-2-[[(2S)-3-hydroxy-2-[[(2S,3S)-3-methyl-2-[[(2S)-1-[(2S)-1-[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]butanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]pentanoyl]amino]hexanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-methylpentanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]-5-oxopentanoyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylpentanoic acid
   Show/Hide
C202H345N55O64S
 1
1 Ki = 0.8 nM
CP0244594
(1-Ethyl-propyl)-[3-(4-methoxy-2-methyl-phenyl)-2,5-dimethyl-pyrazolo[1,5-a]pyrimidin-7-yl]-amine
   Show/Hide
C21H28N4O
 1
1 Ki = 1 nM
CP0144716
N-(cyclopropylmethyl)-3-(2,4-dichlorophenyl)-2,5-dimethyl-N-propylpyrazolo[1,5-a]pyrimidin-7-amine
   Show/Hide
C21H24Cl2N4
 1
1 Ki = 1.3 nM
CP0722686
Butyl-[2,5-dimethyl-7-(2,4,6-trimethyl-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-ethyl-amine
   Show/Hide
C23H33ClN4
 1
1 Ki = 1.6 nM
CP0042421
5-Chloro-N-cyclopropylmethyl-2-methyl-N-propyl-N''-(2,4,6-trichloro-phenyl)-pyrimidine-4,6-diamine
   Show/Hide
C18H20Cl4N4
 2
1 Ki = 1.7 nM
2 Ki = 2.7 nM
CP0255382
Butyl-[2,5-dimethyl-7-(2,4,6-trimethyl-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-ethyl-amine
   Show/Hide
C23H32N4
 1
1 Ki = 2.7 nM
CP0116903
3-(6-(dimethylamino)-4-methylpyridin-3-yl)-2,5-dimethyl-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-amine
   Show/Hide
C22H32N6
 1
1 Ki = 3 nM
CP0789127
(2-Chloro-4,6-dimethyl-phenyl)-[1-(2-methoxy-1-methoxymethyl-ethyl)-6-methyl-1H-[1,2,3]triazolo[4,5-c]pyridin-4-yl]-amine; compound with methanesulfonic acid
   Show/Hide
C20H28ClN5O5S
 1
1 Ki = 3.3 nM
CP0279533
3-(2,4-dimethoxyphenyl)-N-(2-methoxyethyl)-2,5-dimethyl-N-propylpyrazolo[1,5-a]pyrimidin-7-amine
   Show/Hide
C22H30N4O3
 1
1 Ki = 3.4 nM
CP0310325
3-(2-Bromo-4-isopropyl-phenyl)-7-diethylamino-5-methyl-3H-thiazolo[4,5-d]pyrimidine-2-thione
   Show/Hide
C19H23BrN4S2
 1
1 Ki = 4.1 nM
CP0274618
9-(2-Bromo-4-isopropyl-phenyl)-6-(butyl-ethyl-amino)-2,7-dimethyl-7,9-dihydro-purin-8-one
   Show/Hide
C22H30BrN5O
 1
1 Ki = 5 nM
CP0289537
Butyl-[3-(2,4-dichloro-phenyl)-2,5-dimethyl-pyrazolo[1,5-a]pyrimidin-7-yl]-ethyl-amine
   Show/Hide
C20H24Cl2N4
 1
1 Ki = 5 nM
CP0275845
2-N-(2-bromo-4-propan-2-ylphenyl)-2-N-ethyl-6-methyl-4-N,4-N-dipropylpyrimidine-2,4-diamine
   Show/Hide
C22H33BrN4
 1
1 Ki = 9 nM
CP0040853
2,5-dimethyl-3-(3-methyl-5-nitropyridin-2-yl)-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-amine
   Show/Hide
C20H26N6O2
 1
1 Ki = 9.1 nM
CP0182111
3-(2-Bromo-4-isopropyl-phenyl)-7-diethylamino-5-methyl-3H-thiazolo[4,5-d]pyrimidin-2-one
   Show/Hide
C19H23BrN4OS
 1
1 Ki = 9.4 nM
CP0295460
3-[5-(dimethylamino)-3-methylpyridin-2-yl]-2,5-dimethyl-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-amine
   Show/Hide
C22H32N6
 1
1 Ki = 10 nM
CP0289681
3-(5-amino-3-methylpyridin-2-yl)-2,5-dimethyl-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-amine
   Show/Hide
C20H28N6
 1
1 Ki = 85 nM
Clinical Information about the Protein
Target 1 ( Corticotropin-releasing factor receptor 1 (CRHR1) )
Target Type Successful Target
Disease 5 Target-related Diseases  5
1 Anxiety disorder [ICD-11: 6B00-6B0Z]
2 Major depressive disorder [ICD-11: 6A70.3]
3 Mood disorder [ICD-11: 6A60-6E23]
4 Irritable bowel syndrome [ICD-11: DD91.0]
5 Depression [ICD-11: 6A70-6A7Z]
Clinical Trial Drug(s) 4 Clinical Trial Drugs  4
1 Pexacerfont Phase 2/3
Anxiety disorder
2 GSK561679 Phase 2
Major depressive disorder
3 ONO-2333Ms Phase 2
Anxiety disorder
4 SSR125543 Phase 2
Anxiety disorder
Discontinued Drug(s) 4 Discontinued Drugs  4
1 CP-316,311 Discontinued in Phase 2
Mood disorder
2 GW876008 Discontinued in Phase 2
Irritable bowel syndrome
3 Antalarmin Terminated
Depression
4 DMP-696 Terminated
Anxiety disorder
Investigative Drug(s) 3 Investigative Drugs  3
1 BMS-561388 Investigative
Anxiety disorder
2 CP154,526 Investigative
Depression
3 Des-Arg(9)-[Leu(8)]-BK Investigative
Depression